NCI is the nation's trusted source for cancer information
Regorafenib is the first drug approved for liver cancer in nearly a decade.
Our evidence-based information covers treatment, causes, screening, and more.
With our new basic search form, you can find a trial or contact the NCI for help via phone, email, or online chat.
Learn more about treatment
Supportive information on managing the physical and emotional effects of cancer and treatment for both patients and caregivers.
Information to help with talking about and coping with advanced cancer, making choices about care, and planning for the end of life.
Information on choosing a doctor or treatment facility, home care, financial help, insurance coverage, end-of-life planning, and resources to help you avoid scams.
Learn the factors associated with cancer disparities, examples of how the cancer burden differs across populations, and NCI’s role in studying, understanding, and reducing disparities.
NCI offers free information on cancer topics in English and Spanish. Get live help at 1-800-4-CANCER.
